Pediatric Idiopathic Intracranial Hypertension

Abstract

Idiopathic intracranial hypertension (IIH) is a condition of elevated intracranial pressure (ICP) of unknown cause. In adults, this is associated with female gender and obesity. Symptoms may include headaches, diplopia, pulsatile tinnitus, and vision loss due to papilledema. Children may develop IIH, although the demographics of prepubescent children with IIH appear to be distinct from older children, being independent of gender and obesity. Recent diagnostic criteria have been established specifically for children with IIH, including a different normal range of ICP in children. Treatments may include weight loss, carbonic anhydrase inhibitors, or surgical procedures. The visual prognosis of children treated appropriately is generally good.

Keywords

pseudotumor cerebri - papilledema - idiopathic intracranial hypertension

• References

• 1 Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2012; 83 (5) 488-494
• 2 Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59 (10) 1492-1495
• 3 Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992; 37 (3) 155-166
• 4 Balcer LJ, Liu GT, Forman S , et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999; 52 (4) 870-872
• 5 Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci 1997; 24 (3) 219-221
• 6 Bursztyn LL, Sharan S, Walsh L, LaRoche GR, Robitaille J, De Becker I. Has rising pediatric obesity increased the incidence of idiopathic intracranial hypertension in children?. Can J Ophthalmol 2014; 49 (1) 87-91
• 7 Tibussek D, Distelmaier F, von Kries R, Mayatepek E. Pseudotumor cerebri in childhood and adolescence – results of a Germany-wide ESPED-survey. Klin Padiatr 2013; 225 (2) 81-85
• 8 Brara SM, Koebnick C, Porter AH, Langer-Gould A. Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J Pediatr 2012; 161 (4) 602-607
• 9 Chandra V, Bellur SN, Anderson RJ. Low CSF protein concentration in idiopathic pseudotumor cerebri. Ann Neurol 1986; 19 (1) 80-82
• 10 Johnston PK, Corbett JJ, Maxner CE. Cerebrospinal fluid protein and opening pressure in idiopathic intracranial hypertension (pseudotumor cerebri). Neurology 1991; 41 (7) 1040-1042
• 11 Margeta MA, Buckley EG, El-Dairi MA. Low cerebrospinal fluid protein in prepubertal children with idiopathic intracranial hypertension. J AAPOS 2015; 19 (2) 135-139
• 12 Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996; 46 (1) 198-202
• 13 Farb RI, Vanek I, Scott JN , et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003; 60 (9) 1418-1424
• 14 Bidot S, Saindane AM, Peragallo JH, Bruce BB, Newman NJ, Biousse V. Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmol 2015; 35 (4) 400-411
• 15 Ahmed R, Friedman DI, Halmagyi GM. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol 2011; 31 (4) 374-380
• 16 Stienen A, Weinzierl M, Ludolph A, Tibussek D, Häusler M. Obstruction of cerebral venous sinus secondary to idiopathic intracranial hypertension. Eur J Neurol 2008; 15 (12) 1416-1418
• 17 Tabassi A, Salmasi AH, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 2005; 64 (11) 1893-1896
• 18 Warner JEA, Larson AJ, Bhosale P , et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 2007; 27 (4) 258-262
• 19 Sheldon CA, Kwon YJ, Liu GT, McCormack SE. An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics. Pediatr Res 2015; 77 (2) 282-289
• 20 Paley GL, Sheldon CA, Burrows EK, Chilutti MR, Liu GT, McCormack SE. Overweight and obesity in pediatric secondary pseudotumor cerebri syndrome. Am J Ophthalmol 2015; 159 (2) 344-352.e1
• 21 Rodahl K, Moore T. The vitamin A content and toxicity of bear and seal liver. Biochem J 1943; 37 (2) 166-168
• 22 Chiu AM, Chuenkongkaew WL, Cornblath WT , et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998; 126 (1) 116-121
• 23 Gardner K, Cox T, Digre KB. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review. Neurology 1995; 45 (1) 6-10
• 24 Quinn AG, Singer SB, Buncic JR. Pediatric tetracycline-induced pseudotumor cerbri. J AAPOS 1999; 3 (1) 53-57
• 25 Fraunfelder FW, Fraunfelder FT, Corbett JJ. Isotretinoin-associated intracranial hypertension. Ophthalmology 2004; 111 (6) 1248-1250
• 26 Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol 2005; 6 (1) 29-37
• 27 Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 1995; 55 (3) 165-168
• 28 Guirgis MF, Lueder GT. Intracranial hypertension secondary to all-trans retinoic acid treatment for leukemia: diagnosis and management. J AAPOS 2003; 7 (6) 432-434
• 29 Sano F, Tsuji K, Kunika N , et al. Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid. Intern Med 1998; 37 (6) 546-549
• 30 Kelly SJ, O'Donnell T, Fleming JC, Einhaus S. Pseudotumor cerebri associated with lithium use in an 11-year-old boy. J AAPOS 2009; 13 (2) 204-206
• 31 Hexom B, Barthel RP. Lithium and pseudotumor cerebri. J Am Acad Child Adolesc Psychiatry 2004; 43 (3) 247-248
• 32 Somech R, Doyle J. Pseudotumor cerebri after allogeneic bone marrow transplant associated with cyclosporine a use for graft-versus-host disease prophylaxis. J Pediatr Hematol Oncol 2007; 29 (1) 66-68
• 33 Morente GB, Sánchez JT, Colmenero CG, García EM, Molina-Carballo A. Pseudotumor cerebri associated with cyclosporine use in severe atopic dermatitis. Pediatr Dermatol 2013; 32 (2) 237-239
• 34 Costa KM, Almeida JB, Félix RH, Silva Júnior MF. [Pseudotumor cerebri associated with cyclosporin use following renal transplantation]. J Bras Nefrol 2010; 32 (1) 136-139
• 35 Büscher R, Vij O, Hudde T, Hoyer PF, Vester U. Pseudotumor cerebri following cyclosporine A treatment in a boy with tubulointerstitial nephritis associated with uveitis. Pediatr Nephrol 2004; 19 (5) 558-560
• 36 Fort JA, Smith LD. Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl. Ann Pharmacother 1999; 33 (5) 576-578
• 37 Gedroyc W, Shorvon SD. Acute intracranial hypertension and nalidixic acid therapy. Neurology 1982; 32 (2) 212-215
• 38 Alexandrakis G, Filatov V, Walsh T. Pseudotumor cerebri in a 12-year-old boy with Addison's disease. Am J Ophthalmol 1993; 116 (5) 650-651
• 39 Condulis N, Germain G, Charest N, Levy S, Carpenter TO. Pseudotumor cerebri: a presenting manifestation of Addison's disease. Clin Pediatr (Phila) 1997; 36 (12) 711-713
• 40 Campos SP, Olitsky S. Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism. Clin Pediatr (Phila) 1995; 34 (6) 334-337
• 41 Raghavan S, DiMartino-Nardi J, Saenger P, Linder B. Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr 1997; 130 (3) 478-480
• 42 Merkenschlager A, Ehrt O, Müller-Felber W, Schmidt H, Bernhard MK. Reversible benign intracranial hypertension in a child with hyperthyroidism. J Pediatr Endocrinol Metab 2008; 21 (11) 1099-1101
• 43 Loukianou E, Tasiopoulou A, Demosthenous C, Brouzas D. Pseudotumor cerebri in a child with idiopathic growth hormone insufficiency two months after initiation of recombinant human growth hormone treatment. Case Rep Ophthalmol Med 2016; 2016: 4756894
• 44 Sebestyen J, Warady BA. Pseudotumor cerebri in a toddler receiving recombinant human growth hormone. Perit Dial Int 2010; 30 (4) 477-478
• 45 Besch D, Makowski C, Steinborn MM, Bonfig W, Sadowski B. Visual loss without headache in children with pseudotumor cerebri and growth hormone treatment. Neuropediatrics 2013; 44 (4) 203-207
• 46 Noto R, Maneatis T, Frane J, Alexander K, Lippe B, Davis DA. Intracranial hypertension in pediatric patients treated with recombinant human growth hormone: data from 25 years of the Genentech National Cooperative Growth Study. J Pediatr Endocrinol Metab 2011; 24 (9–10): 627-631
• 47 Ray WZ, Lee A, Blackburn SL, Lueder GT, Leonard JR. Pseudotumor cerebri following tapered corticosteroid treatment in an 8-month-old infant. J Neurosurg Pediatr 2008; 1 (1) 88-90
• 48 Liu GT, Kay MD, Bienfang DC, Schatz NJ. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol 1994; 117: 352-357
• 49 Levine A, Watemberg N, Hager H, Bujanover Y, Ballin A, Lerman-Sagie T. Benign intracranial hypertension associated with budesonide treatment in children with Crohn's disease. J Child Neurol 2001; 16 (6) 458-461
• 50 Arber N, Shirin H, Fadila R, Melamed E, Pinkhas J, Sidi Y. Pseudotumor cerebri associated with leuprorelin acetate. Lancet 1990; 335 (8690): 668
• 51 Neely DE, Plager DA, Kumar N. Desmopressin (DDAVP)-induced pseudotumor cerebri. J Pediatr 2003; 143 (6) 808
• 52 Vargiami E, Zafeiriou DI, Gombakis NP, Kirkham FJ, Athanasiou-Metaxa M. Hemolytic anemia presenting with idiopathic intracranial hypertension. Pediatr Neurol 2008; 38 (1) 53-54
• 53 Tavil B, Karakurt N, Bozkaya I, Çulha V, Mehmet Azk F, Tunç B. Pseudotumor cerebri in a Turkish boy with Fanconi anemia. J Pediatr Hematol Oncol 2012; 34 (4) 296-297
• 54 Tugal O, Jacobson R, Berezin S , et al. Recurrent benign intracranial hypertension due to iron deficiency anemia. Case report and review of the literature. Am J Pediatr Hematol Oncol 1994; 16 (3) 266-270
• 55 Biousse V, Rucker JC, Vignal C, Crassard I, Katz BJ, Newman NJ. Anemia and papilledema. Am J Ophthalmol 2003; 135 (4) 437-446
• 56 Segal L, Discepola M. Idiopathic intracranial hypertension and sickle cell disease: two case reports. Can J Ophthalmol 2005; 40 (6) 764-767
• 57 Henry M, Driscoll MC, Miller M, Chang T, Minniti CP. Pseudotumor cerebri in children with sickle cell disease: a case series. Pediatrics 2004; 113 (3 Pt 1): e265-e269
• 58 Bala P, McKiernan J, Gardiner C, O'Connor G, Murray A. Turner's syndrome and benign intracranial hypertension with or without growth hormone treatment. J Pediatr Endocrinol Metab 2004; 17 (9) 1243-1244
• 59 Sybert VP, Bird TD, Salk DJ. Pseudotumour cerebri and the Turner syndrome. J Neurol Neurosurg Psychiatry 1985; 48 (2) 164-166
• 60 Esmaili N, Bradfield YS. Pseudotumor cerebri in children with Down syndrome. Ophthalmology 2007; 114 (9) 1773-1778
• 61 Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol 2007; 52 (6) 597-617
• 62 Jacobson DM. Intracranial hypertension and the syndrome of acquired hyperopia with choroidal folds. J Neuroophthalmol 1995; 15 (3) 178-185
• 63 Schirmer CM, Hedges III TR. Mechanisms of visual loss in papilledema. Neurosurg Focus 2007; 23 (5) E5
• 64 Sibony PA, Kupersmith MJ, Feldon SE, Wang JK, Garvin M ; OCT Substudy Group for the NORDIC Idiopathic Intracranial Hypertension Treatment Trial. Retinal and choroidal folds in papilledema. Invest Ophthalmol Vis Sci 2015; 56 (10) 5670-5680
• 65 Glatstein MM, Oren A, Amarilyio G , et al. Clinical characterization of idiopathic intracranial hypertension in children presenting to the emergency department: the experience of a large tertiary care pediatric hospital. Pediatr Emerg Care 2015; 31 (1) 6-9
• 66 Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol 2002; 17 (10) 745-748
• 67 Soiberman U, Stolovitch C, Balcer LJ, Regenbogen M, Constantini S, Kesler A. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv Syst 2011; 27 (11) 1913-1918
• 68 Masri A, Jaafar A, Noman R, Gharaibeh A, Ababneh OH. Intracranial Hypertension in Children: Etiologies, Clinical Features, and Outcome. J Child Neurol 2015; 30 (12) 1562-1568
• 69 Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81 (13) 1159-1165
• 70 El-Dairi MA, Holgado S, O'Donnell T, Buckley EG, Asrani S, Freedman SF. Optical coherence tomography as a tool for monitoring pediatric pseudotumor cerebri. J AAPOS 2007; 11 (6) 564-570
• 71 Lim MJ, Pushparajah K, Jan W, Calver D, Lin J-P. Magnetic resonance imaging changes in idiopathic intracranial hypertension in children. J Child Neurol 2010; 25 (3) 294-299
• 72 Shofty B, Ben-Sira L, Constantini S, Freedman S, Kesler A. Optic nerve sheath diameter on MR imaging: establishment of norms and comparison of pediatric patients with idiopathic intracranial hypertension with healthy controls. AJNR Am J Neuroradiol 2012; 33 (2) 366-369
• 73 Görkem SB, Doğanay S, Canpolat M , et al. MR imaging findings in children with pseudotumor cerebri and comparison with healthy controls. Childs Nerv Syst 2015; 31 (3) 373-380
• 74 Hartmann AJ, Soares BP, Bruce BB. Imaging features of idiopathic intracranial hypertension (IIH) in children. J Child Neurol 2017; 32 (1) 120-126
• 75 Welch K. The intracranial pressure in infants. J Neurosurg 1980; 52 (5) 693-699
• 76 Avery RA, Shah SS, Licht DJ , et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med 2010; 363 (9) 891-893
• 77 Redzic ZB, Segal MB. The structure of the choroid plexus and the physiology of the choroid plexus epithelium. Adv Drug Deliv Rev 2004; 56 (12) 1695-1716
• 78 Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL ; NORDIC Idiopathic Intracranial Hypertension Study Group. Visual field outcomes for the idiopathic intracranial hypertension treatment trial (IIHTT). Invest Ophthalmol Vis Sci 2016; 57 (3) 805-812
• 79 Çelebisoy N, Gökçay F, Şirin H, Akyürekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007; 116 (5) 322-327
• 80 Saunders KH, Kumar RB, Igel LI, Aronne LJ. Pharmacologic approaches to weight management: recent gains and shortfalls in combating obesity. Curr Atheroscler Rep 2016; 18 (7) 36
• 81 McCarthy KD, Reed DJ. The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 1974; 189 (1) 194-201
• 82 Matthews YY. Drugs used in childhood idiopathic or benign intracranial hypertension. Arch Dis Child Educ Pract Ed 2008; 93 (1) 19-25
• 83 Wong R, Madill SA, Pandey P, Riordan-Eva P. Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 2007; 7: 15
• 84 Niotakis G, Grigoratos D, Chandler C, Morrison D, Lim M. CSF diversion in refractory idiopathic intracranial hypertension: single-centre experience and review of efficacy. Childs Nerv Syst 2013; 29 (2) 263-267
• 85 El-Saadany WF, Farhoud A, Zidan I. Lumboperitoneal shunt for idiopathic intracranial hypertension: patients' selection and outcome. Neurosurg Rev 2012; 35 (2) 239-243 , discussion 243–244
• 86 Ulivieri S, Oliveri G, Georgantzinou M , et al. Long-term effectiveness of lumboperitoneal flow-regulated shunt system for idiopathic intracranial hypertension. J Neurosurg Sci 2009; 53 (3) 107-111
• 87 Huang LC, Winter TW, Herro AM , et al. Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension. J Neuroophthalmol 2014; 34 (3) 223-228
• 88 Kandasamy J, Hayhurst C, Clark S , et al. Electromagnetic stereotactic ventriculoperitoneal csf shunting for idiopathic intracranial hypertension: a successful step forward?. World Neurosurg 2011; 75 (1) 155-160 , discussion 32–33
• 89 Woodworth GF, McGirt MJ, Elfert P, Sciubba DM, Rigamonti D. Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension. Stereotact Funct Neurosurg 2005; 83 (1) 12-16
• 90 Menger RP, Connor Jr DE, Thakur JD , et al. A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample. Neurosurg Focus 2014; 37 (5) E4
• 91 Rogers DL. A review of pediatric idiopathic intracranial hypertension. Pediatr Clin North Am 2014; 61 (3) 579-590
• 92 Fonseca PL, Rigamonti D, Miller NR, Subramanian PS. Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol 2014; 98 (10) 1360-1363
• 93 Thuente DD, Buckley EG. Pediatric optic nerve sheath decompression. Ophthalmology 2005; 112 (4) 724-727
• 94 Bersani TA, Meeker AR, Sismanis DN, Carruth BP. Pediatric and adult vision restoration after optic nerve sheath decompression for idiopathic intracranial hypertension. Orbit 2016; 35 (3) 132-139
• 95 Puffer RC, Mustafa W, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerv Surg 2013; 5 (5) 483-486
• 96 Starke RM, Wang T, Ding D , et al. Endovascular treatment of venous sinus stenosis in idiopathic intracranial hypertension: complications, neurological outcomes, and radiographic results. Sci World J 2015; 2015: 140408
• 97 Arac A, Lee M, Steinberg GK, Marcellus M, Marks MP. Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus 2009; 27 (5) E14
• 98 Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology 2007; 68 (3) 229-232
• 99 Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 1994; 118 (1) 88-96
• 100 Ravid S, Shahar E, Schif A, Yehudian S. Visual outcome and recurrence rate in children with idiopathic intracranial hypertension. J Child Neurol 2015; 30 (11) 1448-1452
• 101 Per H, Canpolat M, Gümüş H , et al. Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain Dev 2013; 35 (6) 561-568
• 102 Tibussek D, Schneider DT, Vandemeulebroecke N , et al. Clinical spectrum of the pseudotumor cerebri complex in children. Childs Nerv Syst 2010; 26 (3) 313-321